Search results for: Vaccines
Filter search results
Meningococcal Vaccines: An International Comparison of Decision-Making Processes, Frameworks and Methodologies. Are Values Missing?
3 January 2020
Meningococcal disease is a life-threatening infection and can result in severe sequelae. Recent scientific and technical advances have led to the discovery and implementation of novel meningococcal vaccines which have…
Public Private Partnerships for Research and Development: Medicines and Vaccines for Diseases of Poverty
1 December 2002
…drugs, vaccines and diagnostics. Achieving the latter is a critical part of a… Improving the health and life expectancy of the populations of the less developed countries of the world…
Incentives for New Drugs and Vaccines to Tackle Anti-Microbial Resistance
16 May 2017
…mechanisms aim to create incentives by creating viable market demand and/or revenues when new products are approved. Pull incentives are key to stimulating R&D for new antibiotics and vaccines. Push…
The Broader Value of Vaccines: The Return on Investment From a Governmental Perspective
1 August 2020
…programs from the UK vaccination schedule was selected for a form of fiscal health modelling. The model is intended to complement the regular cost-effectiveness assessment of vaccines from a health-system…
Vaccines, Antivirals, Lockdowns and COVID: Lessons from the Pandemic
20 October 2022, 3:00pm
…Moderna and Former Senior Expert Policy & Strategy Adviser at the heart of the COVID-19 pandemic for the UK Government on the UK Vaccines Taskforce, Antiviral Taskforce and Therapeutic Taskforce…
Drugs and Vaccines for Developing Countries
1 June 2011
…and initiatives, then, is essential to understanding which policies and programs work well and which do not. Towse, A., Keuffel, E., Kettler, H.E. and Ridley, D.B. Drugs and vaccines for developing…
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?
1 July 2021
…et al. (2021). A number can, and should, be acted upon now. Modifications to existing vaccines are in the pipeline, and more new vaccines in development. We set out in…
The Economics of Innovation in Times of Pandemic: How to Incentivise the Development, Supply, and Continuous Improvement of Innovative Solutions to Fight COVID-19?
22 May 2020
…COVID-19 Impact Fund have been proposed for new tests, products or vaccines. These could be efficient solutions for the first tests, vaccines or treatments making it to the market but…
The Value of Vaccines in Maintaining Health System Capacity in England
1 October 2021
This report has now been published as an article in Value in Health available here. The NHS is facing unprecedented health system pressure, with a record number of patients waiting…